Cover Image
市場調查報告書

全球流感疫苗市場分析與預測

Influenza Vaccines Market and Forecast - Global Analysis

出版商 iGate Research Pvt Ltd 商品編碼 360468
出版日期 內容資訊 英文 176 Pages
訂單完成後即時交付
價格
Back to Top
全球流感疫苗市場分析與預測 Influenza Vaccines Market and Forecast - Global Analysis
出版日期: 2016年02月22日 內容資訊: 英文 176 Pages
簡介

本報告提供全球流感疫苗市場相關調查分析,接種人數與預測,品牌銷售額與預測,主要交易,推動市場要素,課題等系統性資訊。

第1章 摘要整理

第2章 全球流感疫苗市場分析與預測

  • 全球流感疫苗市場與預測
  • 全球流感疫苗接種人數與預測

第3章 全球流感疫苗市場佔有率分析與預測

  • 流感疫苗市場佔有率與預測:各國分析
  • 流感疫苗接種人數佔有率與預測:各國分析

第4章 流感疫苗市場、接種人數與預測:地理分佈

  • 美國
  • 加拿大
  • 巴西
  • 墨西哥
  • 德國
  • 法國
  • 義大利
  • 西班牙
  • 英國
  • 荷蘭
  • 愛爾蘭
  • 丹麥
  • 盧森堡
  • 瑞典
  • 澳洲
  • 紐西蘭
  • 日本
  • 中國
  • 印度
  • 韓國
  • 泰國
  • 新加坡
  • 香港
  • 馬來西亞
  • 印尼

第5章 全球流感疫苗品牌銷售額與預測

  • Fluarix/FluLaval的銷售額與預測
  • Fluzone的銷售額與預測
  • Fluvirin/Flucelvax的銷售額與預測
  • Influvac (Abbott收購)的銷售額
  • Afluria/Fluvax的銷售額與預測
  • FluMist/Fluenz的銷售額與預測
  • Flublo的銷售額與預測

第6章 流感疫苗市場:主要交易

  • M&A
  • 授權合約

第7章 全球流感疫苗市場:推動因素

第8章 全球流感疫苗市場:課題

圖表

目錄

The influenza vaccine is one of the most lucrative segment of the global vaccines market. Influenza is a highly communicable disease and typically has the most severe impact on children and the elderly. Influenza viruses are considered as a major cause of morbidity and mortality worldwide. The vast population base together with significantly low vaccination coverage in emerging markets, rising government support for immunization and growing awareness of the value of influenza vaccine in preventing disease are the prominent factors that will fuel the growth of the influenza vaccines market.

In the influenza vaccines market, United States captures majority of the market share. Japan is the second leading market for influenza vaccines with around XX% share in 2015. China and India are the third and fourth leading market for influenza vaccines with XX% and XX% market share respectively in 2015. Brazil, Germany, France, UK, Italy, Spain and South Korea are the other leading market for influenza vaccines.

In the influenza vaccines brand sales segment, Sanofi's Fluzone holds the maximum share of the market being followed by Fluvirin/Flucelvax. GSK's Fluarix/FluLaval accounts for the third highest share of the influenza vaccines market. FluMist/Fluenz and Afluria/Fluvax stands at the fourth and fifth position in the influenza vaccines market, while Flublok has captured least share of the influenza vaccines market.

iGATE Research report titled “Influenza Vaccines Market and Forecast - Global Analysis” provides a comprehensive analysis of the fast-evolving influenza vaccines market. This 176 Page report contains 117 Figures and 8 Tables to present a clear picture of the influenza vaccines market landscape.

The Influenza Vaccines Market have been analyzed from 4 viewpoints:

  • 1. Influenza Vaccines Market, Persons Vaccinated and Forecast - Geographical Distribution (2011 - 2021)
  • 2. Global - Influenza Vaccines Brand Sales and Forecast to 2021
  • 3. Global Influenza Vaccines Market - Major Deals
  • 4. Global Influenza Vaccines Market - Driving Factors and Challenges

Influenza Vaccines Market, Persons Vaccinated and Forecast - Geographical Distribution (25 Countries Covered)

  • 1. United States
  • 2. Canada
  • 3. Brazil
  • 4. Mexico
  • 5. Germany
  • 6. France
  • 7. Italy
  • 8. Spain
  • 9. United Kingdom
  • 10. Netherlands
  • 11. Ireland
  • 12. Denmark
  • 13. Luxembourg
  • 14. Sweden
  • 15. Australia
  • 16. New Zealand
  • 17. Japan
  • 18. China
  • 19. India
  • 20. South Korea
  • 21. Singapore
  • 22. Hong Kong
  • 23. Malaysia
  • 24. Thailand
  • 25. Indonesia

Global Influenza Vaccines Brand Sales and Forecast - 7 Brands Analyzed

  • 1. Fluarix/FluLaval
  • 2. Fluzone
  • 3. Fluvirin/Flucelvax
  • 4. Influvac
  • 5. Afluria/Fluvax
  • 6. FluMist/Fluenz
  • 7. Flublok

Data Sources

iGATE RESEARCH employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. This report is built by using data and information sourced from Proprietary Information Database, Primary and Secondary Research Methodologies, and In house analysis by iGATE Research dedicated team of qualified professionals with deep industry experience and expertise.

Research Methodologies

Primary Research Methodologies: Questionnaires, Surveys, Interviews with Individuals, Small Groups, Telephonic Interview, etc.

Secondary Research Methodologies: Printable and Non-printable sources, Newspaper, Magazine and Journal Content, Government and NGO Statistics, white Papers, Information on the Web, Information from Agencies Such as Industry Bodies, Companies Annual Report, Government Agencies, Libraries and Local Councils and a large number of Paid Databases.

Table of Contents

1. Executive Summary

2. Global - Influenza Vaccines Market Analysis and Forecast (2011 - 2020)

  • 2.1 Global - Influenza Vaccines Market and Forecast (2011 - 2021)
  • 2.2 Global - Number of Persons Vaccinated with Influenza Vaccines and Forecast (2011 - 2021)

3. Global - Influenza Vaccines Market Share Analysis and Forecast

  • 3.1 Influenza Vaccines Market Share and Forecast - Country Wise Analysis (2011 - 2021)
  • 3.2 Persons Being Vaccinated with Influenza Vaccines Share and Forecast - Country Wise Analysis (2011 - 2021)

4. Influenza Vaccines Market, Persons Vaccinated and Forecast - Geographical Distribution (2011 - 2021)

  • 4.1 United States - Influenza Vaccines Market, Persons Vaccinated and Forecast
    • 4.1.1 United States - Number of Persons Vaccinated with Influenza Vaccines and Forecast
    • 4.1.2 United States - Influenza Vaccines Market and Forecast
  • 4.2 Canada - Influenza Vaccines Market, Persons Vaccinated and Forecast
    • 4.2.1 Canada - Number of Persons Vaccinated with Influenza Vaccines and Forecast
    • 4.2.2 Canada - Influenza Vaccines Market and Forecast
  • 4.3 Brazil - Influenza Vaccines Market, Persons Vaccinated and Forecast
    • 4.3.1 Brazil - Number of Persons Vaccinated with Influenza Vaccines and Forecast
    • 4.3.2 Brazil - Influenza Vaccines Market and Forecast
  • 4.4 Mexico - Influenza Vaccines Market, Persons Vaccinated and Forecast
    • 4.4.1 Mexico - Number of Persons Vaccinated with Influenza Vaccines and Forecast
    • 4.4.2 Mexico - Influenza Vaccines Market and Forecast
  • 4.5 Germany - Influenza Vaccines Market, Persons Vaccinated and Forecast
    • 4.5.1 Germany - Number of Persons Vaccinated with Influenza Vaccines and Forecast
    • 4.5.2 Germany - Influenza Vaccines Market and Forecast
  • 4.6 France - Influenza Vaccines Market, Persons Vaccinated and Forecast
    • 4.6.1 France - Number of Persons Vaccinated with Influenza Vaccines and Forecast
    • 4.6.2 France - Influenza Vaccines Market and Forecast
  • 4.7 Italy - Influenza Vaccines Market, Persons Vaccinated and Forecast
    • 4.7.1 Italy - Number of Persons Vaccinated with Influenza Vaccines and Forecast
    • 4.7.2 Italy - Influenza Vaccines Market and Forecast
  • 4.8 Spain - Influenza Vaccines Market, Persons Vaccinated and Forecast
    • 4.8.1 Spain - Number of Persons Vaccinated with Influenza Vaccines and Forecast
    • 4.8.2 Spain - Influenza Vaccines Market and Forecast
  • 4.9 United Kingdom - Influenza Vaccines Market, Persons Vaccinated and Forecast
    • 4.9.1 United Kingdom - Number of Persons Vaccinated with Influenza Vaccines and Forecast
    • 4.9.2 United Kingdom - Influenza Vaccines Market and Forecast
  • 4.10 Netherlands - Influenza Vaccines Market, Persons Vaccinated and Forecast
    • 4.10.1 Netherlands - Number of Persons Vaccinated with Influenza Vaccines and Forecast
    • 4.10.2 Netherlands - Influenza Vaccines Market and Forecast
  • 4.11 Ireland - Influenza Vaccines Market, Persons Vaccinated and Forecast
    • 4.11.1 Ireland - Number of Persons Vaccinated with Influenza Vaccines and Forecast
    • 4.11.2 Ireland - Influenza Vaccines Market and Forecast
  • 4.12 Denmark - Influenza Vaccines Market, Persons Vaccinated and Forecast
    • 4.12.1 Denmark - Number of Persons Vaccinated with Influenza Vaccines and Forecast
    • 4.12.2 Denmark - Influenza Vaccines Market and Forecast
  • 4.13 Luxembourg - Influenza Vaccines Market, Persons Vaccinated and Forecast
    • 4.13.1 Luxembourg - Number of Persons Vaccinated with Influenza Vaccines and Forecast
    • 4.13.2 Luxembourg - Influenza Vaccines Market and Forecast
  • 4.14 Sweden - Influenza Vaccines Market, Persons Vaccinated and Forecast
    • 4.14.1 Sweden - Number of Persons Vaccinated with Influenza Vaccines and Forecast
    • 4.14.2 Sweden - Influenza Vaccines Market and Forecast
  • 4.15 Australia - Influenza Vaccines Market, Persons Vaccinated and Forecast
    • 4.15.1 Australia - Number of Persons Vaccinated with Influenza Vaccines and Forecast
    • 4.15.2 Australia - Influenza Vaccines Market and Forecast
  • 4.16 New Zealand - Influenza Vaccines Market, Persons Vaccinated and Forecast
    • 4.16.1 New Zealand - Number of Persons Vaccinated with Influenza Vaccines and Forecast
    • 4.16.2 New Zealand - Influenza Vaccines Market and Forecast
  • 4.17 Japan - Influenza Vaccines Market, Persons Vaccinated and Forecast
    • 4.17.1 Japan - Number of Persons Vaccinated with Influenza Vaccines and Forecast
    • 4.17.2 Japan - Influenza Vaccines Market and Forecast
  • 4.18 China - Influenza Vaccines Market, Persons Vaccinated and Forecast
    • 4.18.1 China - Number of Persons Vaccinated with Influenza Vaccines and Forecast
    • 4.18.2 China - Influenza Vaccines Market and Forecast
  • 4.19 India - Influenza Vaccines Market, Persons Vaccinated and Forecast
    • 4.19.1 India - Number of Persons Vaccinated with Influenza Vaccines and Forecast
    • 4.19.2 India - Influenza Vaccines Market and Forecast
  • 4.20 South Korea - Influenza Vaccines Market, Persons Vaccinated and Forecast
    • 4.20.1 South Korea - Number of Persons Vaccinated with Influenza Vaccines and Forecast
    • 4.20.2 South Korea - Influenza Vaccines Market and Forecast
  • 4.21 Thailand - Influenza Vaccines Market, Persons Vaccinated and Forecast
    • 4.21.1 Thailand - Number of Persons Vaccinated with Influenza Vaccines and Forecast
    • 4.21.2 Thailand - Influenza Vaccines Market and Forecast
  • 4.22 Singapore - Influenza Vaccines Market, Persons Vaccinated and Forecast
    • 4.22.1 Singapore - Number of Persons Vaccinated with Influenza Vaccines and Forecast
    • 4.22.2 Singapore - Influenza Vaccines Market and Forecast
  • 4.23 Hong Kong - Influenza Vaccines Market, Persons Vaccinated and Forecast
    • 4.23.1 Hong Kong - Number of Persons Vaccinated with Influenza Vaccines and Forecast
    • 4.23.2 Hong Kong - Influenza Vaccines Market and Forecast
  • 4.24 Malaysia - Influenza Vaccines Market, Persons Vaccinated and Forecast
    • 4.24.1 Malaysia - Number of Persons Vaccinated with Influenza Vaccines and Forecast
    • 4.24.2 Malaysia - Influenza Vaccines Market and Forecast
  • 4.25 Indonesia - Influenza Vaccines Market, Persons Vaccinated and Forecast
    • 4.25.1 Indonesia - Number of Persons Vaccinated with Influenza Vaccines and Forecast
    • 4.25.2 Indonesia - Influenza Vaccines Market and Forecast

5. Global - Influenza Vaccines Brand Sales and Forecast

  • 5.1 Global - Fluarix / FluLaval Sales and Forecast (2007 - 2021)
  • 5.2 Global - Fluzone Sales and Forecast (2009 - 2021)
  • 5.3 Global - Fluvirin/Flucelvax Sales and Forecast (2010 - 2021)
  • 5.4 Global - Influvac (Acquired by Abbott) Sales (2007 - 2009)
  • 5.5 Global - Afluria/Fluvax Sales and Forecast (2010 - 2021)
  • 5.6 Global - FluMist/Fluenz Sales and Forecast (2007 - 2021)
  • 5.7 Global - Flublok Sales and Forecast (2013 - 2021)

6. Influenza Vaccines Market - Major Deals

  • 6.1 Mergers and Acquisitions
  • 6.2 Licensing Agreements

7. Global Influenza Vaccines Market - Driving Factors

  • 7.1 Transformation of Vaccine Technologies
  • 7.2 Vaccines most Cost Effective Means of Disease Prevention
  • 7.3 Scientific & Technological Breakthroughs
  • 7.4 Continuous Focus on Effective Communication Strategies
  • 7.5 Increasing Awareness on Seasonal Influenza & Vaccination

8. Global Influenza Vaccines Market - Challenges

  • 8.1 Complexity of Vaccine Development and Approval System Thwarts Product Development
    • 8.1.1 Legal Obstacles
    • 8.1.2 General Technical Barriers
    • 8.1.3 Economic Barriers
    • 8.1.4 Regulatory Barriers
  • 8.2 Hurdles to Optimal use of Licensed Vaccines
    • 8.2.1 Technical Obstacles
    • 8.2.2 Economic obstacles
    • 8.2.3 Cultural Obstacles
  • 8.3 Barriers to New Entrants in the Vaccines Market
  • 8.4 Reducing the Timeline for Vaccine Development
  • 8.5 Challenges Faced by Healthcare Workers in Immunization

List of Figures:

  • Figure 2-1: Global - Influenza Vaccines Market (Million US$), 2011 - 2015
  • Figure 2-2: Global - Forecast for Influenza Vaccines Market (Million US$), 2016 - 2021
  • Figure 2-3: Global - Number of Persons Vaccinated with Influenza Vaccines (Million), 2011 - 2015
  • Figure 2-4: Global - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2016 - 2021
  • Figure 4-1: United States - Number of Persons Vaccinated with Influenza Vaccines (Million), 2011 - 2015
  • Figure 4-2: United States - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2016 - 2021
  • Figure 4-3: United States - Influenza Vaccines Market (Million US$), 2011 - 2015
  • Figure 4-4: United States - Forecast for Influenza Vaccines Market (Million US$), 2016 - 2021
  • Figure 4-5: Canada - Number of Persons Vaccinated with Influenza Vaccines (Million), 2011 - 2015
  • Figure 4-6: Canada - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2016 - 2021
  • Figure 4-7: Canada - Influenza Vaccines Market (Million US$), 2011 - 2015
  • Figure 4-8: Canada - Forecast for Influenza Vaccines Market (Million US$), 2016 - 2021
  • Figure 4-9: Brazil - Number of Persons Vaccinated with Influenza Vaccines (Million), 2011 - 2015
  • Figure 4-10: Brazil - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2016 - 2021
  • Figure 4-11: Brazil - Influenza Vaccines Market (Million US$), 2011 - 2015
  • Figure 4-12: Brazil - Forecast for Influenza Vaccines Market (Million US$), 2016 - 2021
  • Figure 4-13: Mexico - Number of Persons Vaccinated with Influenza Vaccines (Million), 2011 - 2015
  • Figure 4-14: Mexico - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2016 - 2021
  • Figure 4-15: Mexico - Influenza Vaccines Market (Million US$), 2011 - 2015
  • Figure 4-16: Mexico - Forecast for Influenza Vaccines Market (Million US$), 2016 - 2021
  • Figure 4-17: Germany - Number of Persons Vaccinated with Influenza Vaccines (Million), 2011 - 2015
  • Figure 4-18: Germany - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2016 - 2021
  • Figure 4-19: Germany - Influenza Vaccines Market (Million US$), 2011 - 2015
  • Figure 4-20: Germany - Forecast for Influenza Vaccines Market (Million US$), 2016 - 2021
  • Figure 4-21: France - Number of Persons Vaccinated with Influenza Vaccines (Million), 2011 - 2015
  • Figure 4-22: France - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2016 - 2021
  • Figure 4-23: France - Influenza Vaccines Market (Million US$), 2011 - 2015
  • Figure 4-24: France - Forecast for Influenza Vaccines Market (Million US$), 2016 - 2021
  • Figure 4-25: Italy - Number of Persons Vaccinated with Influenza Vaccines (Million), 2011 - 2015
  • Figure 4-26: Italy - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2016 - 2021
  • Figure 4-27: Italy - Influenza Vaccines Market (Million US$), 2011 - 2015
  • Figure 4-28: Italy - Forecast for Influenza Vaccines Market (Million US$), 2016 - 2021
  • Figure 4-29: Spain - Number of Persons Vaccinated with Influenza Vaccines (Million), 2011 - 2015
  • Figure 4-30: Spain - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2016 - 2021
  • Figure 4-31: Spain - Influenza Vaccines Market (Million US$), 2011 - 2015
  • Figure 4-32: Spain - Forecast for Influenza Vaccines Market (Million US$), 2016 - 2021
  • Figure 4-33: United Kingdom - Number of Persons Vaccinated with Influenza Vaccines (Million), 2011 - 2015
  • Figure 4-34: United Kingdom - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2016 - 2021
  • Figure 4-35: United Kingdom - Influenza Vaccines Market (Million US$), 2011 - 2015
  • Figure 4-36: United Kingdom - Forecast for Influenza Vaccines Market (Million US$), 2016 - 2021
  • Figure 4-37: Netherlands - Number of Persons Vaccinated with Influenza Vaccines (Million), 2011 - 2015
  • Figure 4-38: Netherlands - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2016 - 2021
  • Figure 4-39: Netherlands - Influenza Vaccines Market (Million US$), 2011 - 2015
  • Figure 4-40: Netherlands - Forecast for Influenza Vaccines Market (Million US$), 2016 - 2021
  • Figure 4-41: Ireland - Number of Persons Vaccinated with Influenza Vaccines (Million), 2011 - 2015
  • Figure 4-42: Ireland - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2016 - 2021
  • Figure 4-43: Ireland - Influenza Vaccines Market (Million US$), 2011 - 2015
  • Figure 4-44: Ireland - Forecast for Influenza Vaccines Market (Million US$), 2016 - 2021
  • Figure 4-45: Denmark - Number of Persons Vaccinated with Influenza Vaccines (Million), 2011 - 2015
  • Figure 4-46: Denmark - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2016 - 2021
  • Figure 4-47: Denmark - Influenza Vaccines Market (Million US$), 2011 - 2015
  • Figure 4-48: Denmark - Forecast for Influenza Vaccines Market (Million US$), 2016 - 2021
  • Figure 4-49: Luxembourg - Number of Persons Vaccinated with Influenza Vaccines (Million), 2011 - 2015
  • Figure 4-50: Luxembourg - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2016 - 2021
  • Figure 4-51: Luxembourg - Influenza Vaccines Market (Million US$), 2011 - 2015
  • Figure 4-52: Luxembourg - Forecast for Influenza Vaccines Market (Million US$), 2016 - 2021
  • Figure 4-53: Sweden - Number of Persons Vaccinated with Influenza Vaccines (Million), 2011 - 2015
  • Figure 4-54: Sweden - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2016 - 2021
  • Figure 4-55: Sweden - Influenza Vaccines Market (Million US$), 2011 - 2015
  • Figure 4-56: Sweden - Forecast for Influenza Vaccines Market (Million US$), 2016 - 2021
  • Figure 4-57: Australia - Number of Persons Vaccinated with Influenza Vaccines (Million), 2011 - 2015
  • Figure 4-58: Australia - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2016 - 2021
  • Figure 4-59: Australia - Influenza Vaccines Market (Million US$), 2011 - 2015
  • Figure 4-60: Australia - Forecast for Influenza Vaccines Market (Million US$), 2016 - 2021
  • Figure 4-61: New Zealand - Number of Persons Vaccinated with Influenza Vaccines (Million), 2011 - 2015
  • Figure 4-62: New Zealand - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2016 - 2021
  • Figure 4-63: New Zealand - Influenza Vaccines Market (Million US$), 2011 - 2015
  • Figure 4-64: New Zealand - Forecast for Influenza Vaccines Market (Million US$), 2016 - 2021
  • Figure 4-65: Japan - Number of Persons Vaccinated with Influenza Vaccines (Million), 2011 - 2015
  • Figure 4-66: Japan - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2016 - 2021
  • Figure 4-67: Japan - Influenza Vaccines Market (Million US$), 2011 - 2015
  • Figure 4-68: Japan - Forecast for Influenza Vaccines Market (Million US$), 2016 - 2021
  • Figure 4-69: China - Number of Persons Vaccinated with Influenza Vaccines (Million), 2011 - 2015
  • Figure 4-70: China - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2016 - 2021
  • Figure 4-71: China - Influenza Vaccines Market (Million US$), 2011 - 2015
  • Figure 4-72: China - Forecast for Influenza Vaccines Market (Million US$), 2016 - 2021
  • Figure 4-73: India - Number of Persons Vaccinated with Influenza Vaccines (Million), 2011 - 2015
  • Figure 4-74: India - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2016 - 2021
  • Figure 4-75: India - Influenza Vaccines Market (Million US$), 2011 - 2015
  • Figure 4-76: India - Forecast for Influenza Vaccines Market (Million US$), 2016 - 2021
  • Figure 4-77: South Korea - Number of Persons Vaccinated with Influenza Vaccines (Million), 2011 - 2015
  • Figure 4-78: South Korea - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2016 - 2021
  • Figure 4-79: South Korea - Influenza Vaccines Market (Million US$), 2011 - 2015
  • Figure 4-80: South Korea - Forecast for Influenza Vaccines Market (Million US$), 2016 - 2021
  • Figure 4-81: Thailand - Number of Persons Vaccinated with Influenza Vaccines (Million), 2011 - 2015
  • Figure 4-82: Thailand - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2016 - 2021
  • Figure 4-83: Thailand - Influenza Vaccines Market (Million US$), 2011 - 2015
  • Figure 4-84: Thailand - Forecast for Influenza Vaccines Market (Million US$), 2016 - 2021
  • Figure 4-85: Singapore - Number of Persons Vaccinated with Influenza Vaccines (Million), 2011 - 2015
  • Figure 4-86: Singapore - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2016 - 2021
  • Figure 4-87: Singapore - Influenza Vaccines Market (Million US$), 2011 - 2015
  • Figure 4-88: Singapore - Forecast for Influenza Vaccines Market (Million US$), 2016 - 2021
  • Figure 4-89: Hong Kong - Number of Persons Vaccinated with Influenza Vaccines (Million), 2011 - 2015
  • Figure 4-90: Hong Kong - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2016 - 2021
  • Figure 4-91: Hong Kong - Influenza Vaccines Market (Million US$), 2011 - 2015
  • Figure 4-92: Hong Kong - Forecast for Influenza Vaccines Market (Million US$), 2016 - 2021
  • Figure 4-93: Malaysia - Number of Persons Vaccinated with Influenza Vaccines (Million), 2011 - 2015
  • Figure 4-94: Malaysia - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2016 - 2021
  • Figure 4-95: Malaysia - Influenza Vaccines Market (Million US$), 2011 - 2015
  • Figure 4-96: Malaysia - Forecast for Influenza Vaccines Market (Million US$), 2016 - 2021
  • Figure 4-97: Indonesia - Number of Persons Vaccinated with Influenza Vaccines (Million), 2011 - 2015
  • Figure 4-98: Indonesia - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2016 - 2021
  • Figure 4-99: Indonesia - Influenza Vaccines Market (Million US$), 2011 - 2015
  • Figure 4-100: Indonesia - Forecast for Influenza Vaccines Market (Million US$), 2016 - 2021
  • Figure 5-1: Global - Fluarix / Flulaval Influenza Vaccine Sales (Million US$), 2007 - 2015
  • Figure 5-2: Global - Forecast for Fluarix / Flulaval Influenza Vaccine Sales (Million US$), 2016 - 2021
  • Figure 5-3: Global - Fluzone Influenza Vaccine Sales (Million US$), 2009 - 2015
  • Figure 5-4: Global - Forecast for Fluzone Influenza Vaccine Sales (Million US$), 2016 - 2021
  • Figure 5-5: Global - Fluvirin/Flucelvax Influenza Vaccine Sales (Million US$), 2009 - 2015
  • Figure 5-6: Global - Forecast for Fluvirin/Flucelvax Influenza Vaccine Sales (Million US$), 2016 - 2021
  • Figure 5-7: Global - Influvac Influenza Vaccine Sales (Million US$), 2007 - 2009
  • Figure 5-8: Global - Afluria/Fluvax Influenza Vaccine Sales (Million US$), 2010 - 2015
  • Figure 5-9: Global - Forecast for Afluria/Fluvax Influenza Vaccine Sales (Million US$), 2016 - 2021
  • Figure 5-10: Global - FluMist/Fluenz Influenza Vaccine Sales (Million US$), 2007 - 2015
  • Figure 5-11: Global - Forecast for FluMist/Fluenz Influenza Vaccine Sales (Million US$), 2016 - 2021
  • Figure 5-12: Global - Flublok Influenza Vaccine Sales (Million US$), 2013 - 2015
  • Figure 5-13: Global - Forecast for Flublok Influenza Vaccine Sales (Million US$), 2016 - 2021

List of Tables:

  • Table 3-1: Global - Influenza Vaccines Market Share (Percent), 2011 - 2015
  • Table 3-2: Global - Forecast for Influenza Vaccines Market Share (Percent), 2016 - 2021
  • Table 3-3: Global - Persons Vaccinated with Influenza Vaccines Share (Percent), 2011 - 2015
  • Table 3-4: Global - Forecast for Persons Vaccinated with Influenza Vaccines Share (Percent), 2016 - 2021
  • Table 6-1: Global - Mergers and Acquisitions in Influenza Vaccines Market (Million US$), 2005 - 2015
  • Table 6-2: Global - Licensing Agreement in Influenza Vaccines Market (Million US$), 2007 - 2015
  • Table 7-1: Improvement Strategies or Requirements - the Joint Commission and the Project's Collaborating Organizations
  • Table 7-2: Initiatives Taken in Communication, Education, Training & Information Exchange Related to Seasonal Influenza in European Countries, 2009
Back to Top